Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial.
Brose MS, Robinson B, Sherman SI, Krajewska J, Lin CC, Vaisman F, Hoff AO, Hitre E, Bowles DW, Hernando J, Faoro L, Banerjee K, Oliver JW, Keam B, Capdevila J. Brose MS, et al. Among authors: krajewska j. Lancet Oncol. 2021 Aug;22(8):1126-1138. doi: 10.1016/S1470-2045(21)00332-6. Epub 2021 Jul 5. Lancet Oncol. 2021. PMID: 34237250 Clinical Trial.
Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
Handkiewicz-Junak D, Wloch J, Roskosz J, Krajewska J, Kropinska A, Pomorski L, Kukulska A, Prokurat A, Wygoda Z, Jarzab B. Handkiewicz-Junak D, et al. Among authors: krajewska j. J Nucl Med. 2007 Jun;48(6):879-88. doi: 10.2967/jnumed.106.035535. J Nucl Med. 2007. PMID: 17536106 Free article.
Novel therapies for thyroid cancer.
Krajewska J, Jarzab B. Krajewska J, et al. Expert Opin Pharmacother. 2014 Dec;15(18):2641-52. doi: 10.1517/14656566.2014.969240. Epub 2014 Oct 16. Expert Opin Pharmacother. 2014. PMID: 25318585 Review.
Drug safety evaluation of lenvatinib for thyroid cancer.
Krajewska J, Kukulska A, Jarzab B. Krajewska J, et al. Expert Opin Drug Saf. 2015;14(12):1935-43. doi: 10.1517/14740338.2015.1102883. Epub 2015 Oct 20. Expert Opin Drug Saf. 2015. PMID: 26484847 Review.
144 results